1.38
0.05 (3.76%)
| Penutupan Terdahulu | 1.33 |
| Buka | 1.38 |
| Jumlah Dagangan | 5,463 |
| Purata Dagangan (3B) | 57,977 |
| Modal Pasaran | 47,808,580 |
| Harga / Pendapatan (P/E Ke hadapan) | 72.46 |
| Harga / Jualan (P/S) | 2.61 |
| Harga / Buku (P/B) | 21.89 |
| Julat 52 Minggu | |
| Tarikh Pendapatan | 8 Aug 2024 - 12 Aug 2024 |
| Margin Keuntungan | -42.37% |
| Margin Operasi (TTM) | -32.35% |
| EPS Cair (TTM) | -0.540 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | -7.90% |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 365.61% |
| Nisbah Semasa (MRQ) | 5.45 |
| Aliran Tunai Operasi (OCF TTM) | -12.41 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | -7.30 M |
| Pulangan Atas Aset (ROA TTM) | -14.60% |
| Pulangan Atas Ekuiti (ROE TTM) | -129.51% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Medical Devices (US) | Bercampur | Menurun |
| Medical Devices (Global) | Bercampur | Menurun | |
| Stok | Apyx Medical Corporation | Menurun | Menaik |
AISkor Stockmoo
| Konsensus Penganalisis | 1.5 |
| Aktiviti Orang Dalam | NA |
| Volatiliti Harga | 0.5 |
| Purata Bergerak Teknikal | -2.5 |
| Osilator Teknikal | -0.5 |
| Purata | -0.25 |
|
Apyx Medical Corp is an energy technology medical device company. It specializes in developing, manufacturing, and marketing a range of cosmetic and surgical products and technologies, as well as related medical products used in doctor's offices, surgery centers, and hospitals. Its product offerings comprise Renuvion cosmetic technology, which offers plastic surgeons, facial plastic surgeons, and cosmetic physicians the ability to provide controlled heat to the tissue to achieve desired results. The J-Plasma system allows surgeons to operate with a high level of precision and virtually eliminates unintended tissue trauma. It operates in two segments namely: Advanced Energy and Original Equipment Manufacturing (OEM). Its Advanced Energy segment derives the majority of its revenue. |
|
| Sektor | Healthcare |
| Industri | Medical Devices |
| Gaya Pelaburan | Small Value |
| % Dimiliki oleh Orang Dalam | 14.56% |
| % Dimiliki oleh Institusi | 43.51% |
| Julat 52 Minggu | ||
| Julat Harga Sasaran | ||
| Tinggi | 6.00 (Craig-Hallum, 334.78%) | Beli |
| 6.00 (BTIG, 334.78%) | Beli | |
| 6.00 (Roth Capital, 334.78%) | Beli | |
| Median | 6.00 (334.78%) | |
| Purata | 6.00 (334.78%) | |
| Jumlah | 3 Beli | |
| Harga Purata @ Panggilan | 3.32 | |
| Syarikat | Tarikh | Harga Sasaran | Panggilan | Harga @ Panggilan |
|---|---|---|---|---|
| BTIG | 11 Mar 2026 | 6.00 (334.78%) | Beli | 3.12 |
| Craig-Hallum | 11 Mar 2026 | 6.00 (334.78%) | Beli | 3.12 |
| Roth Capital | 16 Dec 2025 | 6.00 (334.78%) | Beli | 3.72 |
Tiada data dalam julat masa ini.
| Tarikh | Jenis | Butiran |
|---|---|---|
| 29 Jan 2026 | Pengumuman | Apyx Medical Corporation to Participate at the BTIG 13th Annual MedTech, Digital Health, Life Science & Diagnostic Tools Conference |
| 12 Jan 2026 | Pengumuman | Apyx Medical Corporation Reports Preliminary, Unaudited, Fourth Quarter and Full Year 2025 Revenue Results |
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2026 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |